Evaluation of three methods for typing herpes simplex virus
- PMID: 2831045
- DOI: 10.1007/BF02013066
Evaluation of three methods for typing herpes simplex virus
Abstract
Three methods of typing herpes simplex virus were compared. A total of 111 clinical isolates obtained from patients not treated with antivirals and seven resistant mutants selected in vitro were tested by immunofluorescence assay using antibodies against herpes simplex virus types 1 and 2. Twenty-nine isolates were also studied by restriction endonuclease analysis. The sensitivity of isolates and resistant mutants to (E)-5-(2-bromovinyl)-2'-deoxyuridine was determined. Although a clear difference between the 50% inhibitory dose for type 1 and type 2 isolates was observed, some drug-resistant mutants might be misidentified by this method.
Similar articles
-
Identification and typing of herpes simplex virus types 1 and 2 by monoclonal antibodies, sensitivity to the drug (E)-5-(2-bromovinyl)-2'-deoxyuridine, and restriction endonuclease analysis of viral DNA.J Med Virol. 1985 Mar;15(3):215-22. doi: 10.1002/jmv.1890150302. J Med Virol. 1985. PMID: 2984324
-
Herpes simplex virus type 1 that exhibits herpes simplex virus type 2 sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine.Intervirology. 1991;32(5):308-15. doi: 10.1159/000150213. Intervirology. 1991. PMID: 1657822
-
Comparison of four methods for typing low-passage herpes simplex virus isolates.Intervirology. 1985;23(2):112-5. doi: 10.1159/000149593. Intervirology. 1985. PMID: 2984142
-
Inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and related compounds on herpes simplex virus (HSV)-infected cells and HSV thymidine kinase gene-transformed cells.Methods Find Exp Clin Pharmacol. 1989 Jun;11(6):379-89. Methods Find Exp Clin Pharmacol. 1989. PMID: 2545982 Review. No abstract available.
-
The antiviral spectrum of (E)-5-(2-bromovinyl)-2'-deoxyuridine.J Antimicrob Chemother. 1984 Aug;14 Suppl A:85-95. doi: 10.1093/jac/14.suppl_a.85. J Antimicrob Chemother. 1984. PMID: 6092320 Review.